Physician profile
Sally J Irons
NPI 1013011295
$3,315.64
in general payments reported to CMS, 2019-2025
24 companies · $85.41 in 2025
The $85.41 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $269 · 2021: $421 · 2022: $718 · 2023: $976 · 2024: $545 · 2025: $85.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.32 | 2019-2024 | |
| Astellas Pharma US INC | $405.39 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $319.93 | 2019-2024 | Slynd |
| Agile Therapeutics, INC. | $270.15 | 2021-2024 | Twirla |
| Pfizer INC. | $185.19 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $175.10 | 2023-2024 | |
| Coopersurgical, INC. | $151.29 | 2019-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $149.95 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $129.66 | 2023-2024 | Myfembree, Gemtesa |
| Allergan, INC. | $87.34 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.59 | 2022 | |
| Evofem Biosciences, INC. | $66.60 | 2021-2022 | |
| Millicent US INC | $61.43 | 2019-2025 | Femring, Intrarosa |
| Pacira Pharmaceuticals Incorporated | $52.74 | 2023-2024 | Exparel |
| Avion Pharmaceuticals | $44.62 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $42.49 | 2022-2025 | |
| Lupin INC. | $41.57 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.81 | 2023-2024 | |
| Exact Sciences Corporation | $26.11 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $22.19 | 2019 | |
| Urovant Sciences INC | $20.22 | 2022 | |
| Hologic Sales and Service, LLC | $17.40 | 2019 | |
| Daiichi Sankyo INC. | $15.68 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Irons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.